Clinical application of actigraphy in psychotic disorders: A systematic review

Current Psychiatry Reports

Volumn 15, Issue 6, 2013, Pages

  Tahmasian, Masoud ^a,b   Khazaie, Habibolah ^a   Golshani, Sanobar ^a,c   Avis, Kristin T ^d  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d CHILDREN S HOSPITAL OF ALABAMA   (United States)

Author keywords

Actigraphy; Assessment; Circadian rhythms; Diagnosis; Measurement; Motor activity; Movement; Neuropathology; Pharmacological interventions; Psychiatry; Psychosis; Schizophrenia; Sleep; Systematic review

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; BIPERIDEN; CHLORPRATHIXON; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; LORAZEPAM; MOOD STABILIZER; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; UNCLASSIFIED DRUG;

ACTIMETRY; ADULT; AKATHISIA; ARTICLE; CIRCADIAN RHYTHM; DISEASE SEVERITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; POLYSOMNOGRAPHY; PSYCHOSIS; RELIABILITY; SCHIZOPHRENIA; SELF REPORT; SLEEP PATTERN; SLEEP WAKING CYCLE; SYSTEMATIC REVIEW; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SLEEP DISORDER;

ACTIGRAPHY; CIRCADIAN RHYTHM; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SLEEP DISORDERS;

EID: 84877728933     PISSN: 15233812     EISSN: 15351645     Source Type: Journal    
DOI: 10.1007/s11920-013-0359-2     Document Type: Article

References (42)

1. Tahmasian M, Khazaie H, Sepehry AA, Russo MB. Ambulatory monitoring of sleep disorders. J Pak Med Assoc. 2010;60:480-7.
2. • Sadeh A. The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev. 2011;15(4):259-67. In this review, Sadeh discussed validity and reliability of actigraphy and suggested that it is a sensitive tool in detecting unique sleep patterns associated with specific sleep disorders as well as with other medical or neurobehavioral disorders. Clinicians can also use it as an accessory tool for drug treatments and non-pharmacologic interventions.
3. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26:342-92.
4. Yeung WF, Chung KF, Zhang SP, Yap TG, Law AC. Electroacupuncture for primary insomnia: a randomized controlled trial. Sleep. 2009;32:1039-47.
5. Friedman L, Zeitzer JM, Kushida C, Zhdanova I, Noda A, Lee T, et al. Scheduled bright light for treatment of insomnia in older adults. J Am Geriatr Soc. 2009;57:441-52.
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th ed., text rev.). 2000. doi: 10.1176/appi.books. 9780890423349
7. Afonso P, Figueira ML, Paiva T. Sleep-promoting action of the endogenous melatonin in schizophrenia compared to healthy controls. Int J Psychiatry Clin Pract. 2011;15(4):311-5.
8. • Walther S, Federspiel A, Horn H, Razavi N, Wiest R, Dierks T, et al. Resting state cerebral blood flow and objective motor activity reveal basal ganglia dysfunction in schizophrenia. Psychiatry Res Neuroimaging. 2011;192:117-24. This work applied actigraphy as an accessory tool to investigate the relationship between motor functioning and neuropathology in patients with schizophrenia. The researchers used actigraphy with advance techniques such as MRI to have a closer view on the relationship between behavioral and brain level in schizophrenia.
9. • Walther S, Federspiel A, Horn H, Razavi N, Wiest R, Dierks T, et al. Alterations of white matter integrity related to motor activity in schizophrenia. Neurobiol Dis. 2011;42:276-83. This work applied actigraphy as an accessory tool to investigate the relationship between motor functioning and neuropathology in patients with schizophrenia. The researchers used actigraphy with advance techniques such as MRI to have a closer view on the relationship between behavioral and brain level in schizophrenia.
10. • Wichniak A, Skowerska A, Chojnacka-Wojtowicz J, Taflinski T, Wierzbicka A, Jernajczyk W, et al. Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidone. J Psychiatr Res. 2011;45:1381-6. This study used actigraphy to investigate of efficacy of different pharmacological agents in treating secondary sleep impairment in schizophrenia.
11. Waters F, Sinclair C, Rock D, Jablensky A, Foster RG, Wulff K. Daily variations in sleep-wake patterns and severity of psychopathology: a pilot study in community-dwelling individuals with chronic schizophrenia. Psychiat Res. 2011;187:304-6.
12. Hauge ER, Berle JØ, Oedegaard KJ, et al. Nonlinear analysis of motor activity shows differences between schizophrenia and depression: a study using Fourier analysis and sample entropy. PLoS One. 2011;6(1):e16291.
13. Manoach DS, Thakkar KN, Stroynowski E, Ely A, McKinley SK, Wamsley E, et al. Reduced overnight consolidation of procedural learning in chronic medicated schizophrenia is related to specific sleep stages. J Psychiatr Res. 2010;44(2):112-20.
14. Berle JO, Hauge ER, Oedegaard KJ, Holsten F, Fasmer OB. Actigraphic registration of motor activity reveals a more structured behavioural pattern in schizophrenia than in major depression. BMC Res Notes. 2010;3:149.
15. Apiquian R, Fresan A, Munoz-Delgado J, Kiang M, Ulloa RE, Kapur S. Variations of rest-activity rhythm and sleep-wake in schizophrenic patients versus healthy subjects: an actigraphic comparative study. Biol Rhythm Res. 2008;39:69-78.
16. Birkhofer A, Alger P, Schmid G, Froestl H. The cardiovascular risk of schizophrenic patients. Neuropsychiatrie. 2007;21:261-6.
17. Martin JL, Jeste DV, Ancoli-Israel S. Older schizophrenia patients have more disrupted sleep and circadian rhythms than age-matched comparison subjects. J Psychiatr Res. 2005;39:251-9.
18. Shamir E, Laudon M, Barak Y, Anis Y, Rotenberg V, Elizur A, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry. 2000;61:373-7.
19. Dursun SM, Patel JK, Burke JG, Reveley MA. Effects of typical antipsychotic drugs and risperidone on the quality of sleep in patients with schizophrenia: a pilot study. J Psychiatry Neurosci. 1999;24:333-7.
20. Lauerma H, Niskanen L, Lehtinen I, Holmstrom R. Abnormal lateralization of motor-activity during sleep in schizophrenia. Schizophr Res. 1994;14:65-71.
21. Wisniewski A. Application of actigraphy in psychiatry. Psychiatr Pol. 2004;38:1127-43.
22. • Afonso P, Brissos S, Figueira ML, Paiva T. Schizophrenia patients with predominantly positive symptoms have more disturbed sleep-wake cycles measured by actigraphy. Psychiat Res. 2011;189:62-6. This recent work, along with Bromundt et al. [18], evaluted sleep/wake habits and circadian rhythm in patients with schizophrenia. Afonso et al. provided possible evidence that the inadequate sleep may negatively impact quality of life in patients with schizophrenic especially in cases with predominant positive symptoms.
23. Hofstetter JR, Lysaker PH, Mayeda AR. Quality of sleep in patients with schizophrenia is associated with quality of life and coping. BMC Psychiatry. 2005;5:13.
24. Robillard R, Roger N, Whitwell B, Lambert T. Ambulatory sleep-wake patterns and mood disturbances in patients with psychotic disorders: a controlled study. In: Ken-ichi H, editor. Australian sleep association and Australian sleep technologists association 22nd annual scientific meeting. Christchurch, New Zealand: Sleep and Biological Rhythms; 2010. p. A54.
25. Wulff K, Joyce E, Middleton B, Dijk DJ, Foster RG. The suitability of actigraphy, diary data, and urinary melatonin profiles for quantitative assessment of sleep disturbances in schizophrenia: a case report. Chronobiol Int. 2006;23:485-95.
26. Martin J, Jeste DV, Caliguiri MP, Patterson T, Heaton R, Ancoli-Israel S. Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients. Schizophr Res. 2001;47:77-86.
27. • Bromundt V, Koster M, Georgiev-Kill A, Opwis K, Wirz-Justice A, Stoppe G, et al. Sleep-wake cycles and cognitive functioning in schizophrenia. Brit J Psychiatry. 2011;198:269-76. This recent work, along with Afonso et al. [8], evaluted sleep/wake habits and circadian rhythm in patients with schizophrenia. Bromundt et al. found that higher cognitive functioning in patients with schizophrenia was associated with more consolidated circadian rhythms and constant sleep patterns.
28. Haug HJ, Wirz-Justice A, Rossler W. Actigraphy to measure day structure as a therapeutic variable in the treatment of schizophrenic patients. Acta Psychiatr Scand Suppl. 2000:91-5.
29. Haimov I, Reshef A, Bloch B, Vadas L, Hazan L, Blanaru M, et al. Sleep in schizophrenic and PTSD patients: Discrepancy between self reported versus recorded sleep. In: Derk-Jan D, editor. 20th Congress of the European sleep research society. Lisbon, Portugal: Journal of Sleep Research; 2010. p. 140.
30. Walther S, Horn H, Razavi N, Koschorke P, Muller TJ, Strik W. Quantitative motor activity differentiates schizophrenia subtypes. Neuropsychobiology. 2009;60:80-6.
31. Walther S, Horn H, Koschorke P, Muller TJ, Strik W. Increased motor activity in cycloid psychosis compared to schizophrenia. World J Biol Psychiatry. 2009;10:746-51.
32. Khazaie H, Rezaie L, Tahmasian M, Schwebel DC. Insomnia treatment by olanzapine. Is sleep state misperception a psychotic disorder? Neurosciences (Riyadh). 2010;15:110-2.
33. Ross LE, Murray BJ, Steiner M. Sleep and perinatal mood disorders: a critical review. J Psychiatry Neurosci. 2005;30:247-56.
34. Teicher MH. Actigraphy and motion analysis: new tools for psychiatry. Harv Rev Psychiatry. 1995;3(1):18-35.
35. Walther S, Koschorke P, Horn H, Strik W. Objectively measured motor activity in schizophrenia challenges the validity of expert ratings. Psychiatr Res. 2009;169:187-90.
36. Poyurovsky M, Nave R, Epstein R, Tzischinsky O, Schneidman M, Barnes TRE, et al. Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia. Eur Neuropsychopharmacol. 2000;10:171-6.
37. Janno S, Holi MM, Tuisku K, Wahlbeck K. Validity of Simpson-Angus scale (SAS) in a naturalistic schizophrenia population. BMC Neurol. 2005;5(1):5.
38. Janno S, Holi MM, Tuisku K, Wahlbeck K. Actometry and Barnes akathisia rating scale in neuroleptic-induced akathisia. Eur Neuropsychopharmacol. 2005;15:39-41.
39. Janno S, Holi MM, Tuisku K, Wahlbeck K. Neuroleptic-induced movement disorders in a naturalistic schizophrenia population: diagnostic value of actometric movement patterns. BMC Neurol. 2008;8:10. doi: 10.1186/1471-2377-8-10
40. Farrow TF, Hunter MD, Wilkinson ID, Green RD, Spence SA. Structural brain correlates of unconstrained motor activity in people with schizophrenia. Br J Psychiatry. 2005;187:481-2.
41. Kane JM, Krystal AD, McKenzie JE, Yang R, Tiller J, Youakim JM. Sleep in Schizophrenia: a night-and daytime actigraphy study in patients with treated with oral Risperidone, Olanzapine or Paliperidone. Sleep. 2009;32:A355-A.
42. • Walther S, Horn H, Razavi N, Koschorke P, Wopfner A, Muller TJ, et al. Higher motor activity in schizophrenia patients treated with olanzapine versus risperidone. J Clin Psychopharmacol. 2010;30:181-4. This studies used actigraphy to investigate of efficacy of different pharmacological agents in treating secondary sleep impairment in schizophrenia.